CLSD – clearside biomedical, inc. (US:NASDAQ)
Stock Stats
News
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ... [Yahoo! Finance]
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Form 10-Q Clearside Biomedical, For: Sep 30
Form 8-K Clearside Biomedical, For: Nov 12
Form 4 Clearside Biomedical, For: Nov 01 Filed by: Chong Ngai Hang Victor
Form 8-K Clearside Biomedical, For: Oct 09
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.